Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | ACLY | P53396 | 8/20 | 0.49 |
| ▸ | COPS5 | Q92905 | 1/20 | 0.48 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.45 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL473578 | 0.83 | IDO1 (0.56) | IDO1 | |
| SCHEMBL29787088 | 0.83 | IDO1 (0.56) | IDO1 | |
| Trifluoroacetic Acid SCHEMBL6435984 | 0.81 | TP53 (0.48) | IDO1ACLY | |
| Hydrochloric Acid SCHEMBL28650595 | 0.81 | IDO1 (0.57) | IDO1 | |
| Hydrochloric Acid SCHEMBL3591333 | 0.81 | IDO1 (0.57) | IDO1 | |
| Trifluoroacetic Acid SCHEMBL5941732 | 0.81 | TAAR1 (0.67) | TRPV1 | |
| Trifluoroacetic Acid SCHEMBL29484053 | 0.77 | TAAR1 (0.64) | IDO1 | |
| Trifluoroacetic Acid SCHEMBL29484054 | 0.77 | TAAR1 (0.64) | IDO1 | |
| SCHEMBL586345 | 0.76 | PDPK1 (0.59) | ACLYPDPK1HPGD | |
| SCHEMBL30567601 | 0.76 | PDPK1 (0.59) | ACLYPDPK1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1042287-B1 | INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA | AVENTIS PHARMA GMBH (DE) | 2005-04-20 | — | — | EP | disclosed |
| US-6337344-B1 | ANTICOAGULANTS AND ENZYME INHIBITORS FOR CARDIOVASCULAR DISORDERS | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-01-08 | — | — | US | disclosed |
| EP-1042287-A1 | INDOLE DERIVATIVES AS INHIBITORS OF FACTOR XA | Aventis Pharma Deutschland GmbH (DE) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999033800-A1 | INDOLE DERIVATIVES AS INHIBITORS OR FACTOR XA | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 1999-07-08 | — | — | WO | disclosed |